ACET
Adicet Bio Inc.
$8.33
+$0.03(+0.36%)
43
Overall
60
Value
40
Tech
31
Quality
Market Cap
$98.08M
Volume
90.23K
52W Range
$6.01 - $17.44
Target Price
$34.83
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Total Revenue | -- | $995.0K | $17.9M | $9.7M | $704.0K | $714.0K | $727.0K | -- | ||
| Total Revenue | -- | $995.0K | $17.9M | $9.7M | $25.0M | $714.0K | $727.0K | -- | ||
| COST OF GOODS SOLD | ||||||||||
| Cost of Revenue | $-39.7M | $-85.5M | -- | -- | -- | -- | -- | -- | ||
| GROSS PROFIT | ||||||||||
| Gross Profit | $39.7M | $995.0K | $17.9M | $9.7M | $704.0K | $714.0K | $727.0K | -- | ||
| OPERATING EXPENSES | ||||||||||
| Operating Expenses | $-23.1M | $-32.4M | $57.1M | $71.2M | $97.5M | $152.0M | $127.6M | $122.1M | ||
| Research & Development | $31.1M | $23.7M | $34.3M | $48.9M | $71.2M | $106.0M | $99.3M | $99.1M | ||
| Research Expense | $31.1M | $23.7M | $34.3M | $48.9M | $71.2M | $106.0M | $99.3M | $99.1M | ||
| Selling, General & Administrative | $8.6M | $8.7M | $22.8M | $22.2M | $26.3M | $26.5M | $28.3M | $23.0M | ||
| General & Administrative Expenses | $8.6M | $8.7M | $22.8M | $22.2M | $26.3M | $26.5M | $28.3M | $23.0M | ||
| Salaries & Wages | $-2.8M | $-1.2M | -- | -- | -- | $20.3M | -- | -- | ||
| Depreciation & Amortization | $-80.0K | $-1.2M | $1.2M | $1.5M | $2.6M | $6.1M | $6.5M | -- | ||
| Depreciation & Amortization | $-80.0K | $-1.2M | $1.2M | $1.5M | $2.6M | $6.1M | -- | -- | ||
| Amortization | -- | -- | $20.1M | $19.5M | $19.5M | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | $950.0K | $4.3M | $4.5M | $-598.0K | $-221.0K | $-466.0K | ||
| OPERATING INCOME | ||||||||||
| Operating income | $-39.7M | $-31.4M | $-39.2M | $-61.4M | $-72.6M | $-152.0M | $-127.6M | $-122.1M | ||
| EBITDA | $-10.5M | $-27.1M | $-38.1M | $-60.4M | $-67.1M | $-136.5M | $-110.7M | $-110.4M | ||
| NON-OPERATING ITEMS | ||||||||||
| Interest Expense (Non-Operating) | -- | -- | $134.0K | $176.0K | $80.0K | $25.0K | $4.0K | $36.0K | ||
| Interest Income Operating | -- | -- | -- | -- | -- | $10.0M | -- | -- | ||
| Intinc | -- | $938.0K | $785.0K | $91.0K | $3.8M | $10.0M | $10.7M | $5.8M | ||
| Net Non-Operating Interest Income/Expense | -- | $938.0K | $651.0K | $-85.0K | $3.7M | $10.0M | $10.7M | $5.7M | ||
| Gain on Sale of Securities | $2.1M | $2.8M | -- | -- | -- | -- | -- | -- | ||
| Other Income/Expense | $-2.1M | $-2.3M | $953.0K | $606.0K | $-919.0K | $573.0K | $217.0K | $430.0K | ||
| Other Special Charges | $-7.0K | $2.3M | $-953.0K | $-606.0K | $24.1M | $-573.0K | $-217.0K | $-430.0K | ||
| SPECIAL ITEMS | ||||||||||
| Restructring And Mn A Income | -- | $113.2M | $35.8M | -- | -- | -- | -- | -- | ||
| Special Income Charges | -- | $-113.2M | $-35.8M | -- | -- | $-19.5M | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $19.5M | -- | -- | ||
| PRE-TAX INCOME | ||||||||||
| EBIT | $-9.9M | $-28.1M | $-39.4M | $-61.9M | $-69.7M | $-142.6M | $-117.1M | $-116.8M | ||
| Pre-Tax Income | $-9.9M | $-28.1M | $-39.5M | $-62.1M | $-69.8M | $-142.7M | $-117.1M | $-116.8M | ||
| INCOME TAX | ||||||||||
| Tax Provision | $26.0K | $19.0K | $-2.8M | $-125.0K | -- | -- | -- | -- | ||
| NET INCOME | ||||||||||
| Net Income | $-37.6M | $-28.1M | $-36.7M | $-62.0M | $-69.8M | $-142.7M | $-117.1M | $-116.8M | ||
| Net Income (Continuing Operations) | $-37.6M | $-28.1M | $-36.7M | $-62.0M | $-69.8M | $-142.7M | $-117.1M | $-116.8M | ||
| Net Income (Discontinued Operations) | $-37.6M | $-28.1M | $-36.7M | $-62.0M | $-69.8M | $-142.7M | $-117.1M | $-116.8M | ||
| Net Income (Common Stockholders) | $-37.6M | $-28.1M | $-36.7M | $-62.0M | $-69.8M | $-142.7M | $-117.1M | $-116.8M | ||
| Normalized Income | -- | -- | -- | $-61.0M | -- | -- | -- | -- | ||
| TOTALS | ||||||||||
| Total Expenses | $-62.9M | $32.4M | $57.1M | $71.2M | $97.5M | $152.0M | $127.6M | $122.1M | ||
| SHARE & EPS DATA | ||||||||||
| Average Shares Outstanding | $236.1K | $306.3K | $457.5K | $1.9M | $2.6M | $2.7M | $5.5M | $6.9M | ||
| Average Shares Outstanding (Diluted) | $236.5K | $306.5K | $457.5K | -- | $2.6M | $2.7M | $5.5M | $6.9M | ||
| Shares Outstanding | $250.5K | $325.4K | $2.0M | $2.5M | $2.7M | $5.1M | $5.2M | $9.6M | ||
| Basic EPS | -- | -- | $-80.16 | $-32 | $-27.2 | $-52.96 | $-21.28 | $-16.95 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-80.16 | $-32 | $-27.2 | $-52.96 | $-21.28 | $-16.95 | ||
| Diluted EPS | $-159.04 | $-269.92 | $-80.16 | $-32 | $-27.2 | $-52.96 | $-21.28 | $-16.95 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-27.2 | $-52.96 | $-21.28 | $-16.95 | ||
| OTHER METRICS | ||||||||||
| Gain On Sale Of P P E | -- | -- | -- | -- | $-55.0K | $4.0K | -- | -- | ||
| Other Gand A | $8.6M | $8.7M | $22.8M | $22.2M | $26.3M | $26.5M | $28.3M | $23.0M | ||
| Other Impairment Of Capital Assets | -- | -- | $2.3M | $1.2M | -- | -- | -- | -- | ||
| Rent And Landing Fees | $8.6M | $8.7M | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | $113.2M | $35.8M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACET | $8.33 | +0.4% | 90.23K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |